AVDL
$8.14
Avadel Pharmaceuticals Plc ADR
($.08)
(.97%)
AVDL
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.38)
Revenue:  $0.00 Mil
Monday
Nov 8
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AVDL reports earnings?
Beat
Meet
Miss

Where is AVDL's stock price going from here?
Up
Flat
Down
Stock chart of AVDL
Analysts
Summary of analysts' recommendations for AVDL
Score
Grade
Pivots
Resistance
$8.82
$8.52
$8.33

$8.03

Support
$7.84
$7.54
$7.35
Tweet
Growth
Description
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.